Antiandrogens
Aspirin
Bromhexine
Budesonide
Cannabidiol
Casirivimab/i..
Colchicine
Conv. Plasma
Curcumin
Diet
Ensovibep
Exercise
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Melatonin
Metformin
Molnupiravir
Nigella Sativa
Nitazoxanide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Proxalutamide
Quercetin
Remdesivir
Sleep
Sotrovimab
Vitamin A
Vitamin C
Vitamin D
Zinc

Other
Feedback Home
Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Antiandrogens (meta) Lactoferrin (meta)
Aspirin (meta) Melatonin (meta)
Bamlaniv../e.. (meta) Metformin (meta)
Bebtelovimab (meta) Molnupiravir (meta)
Bromhexine (meta) N-acetylcys.. (meta)
Budesonide (meta) Nigella Sativa (meta)
Cannabidiol (meta) Nitazoxanide (meta)
Casirivimab/i.. (meta) Paxlovid (meta)
Colchicine (meta) Peg.. Lambda (meta)
Conv. Plasma (meta) Povidone-Iod.. (meta)
Curcumin (meta) Probiotics (meta)
Diet (meta) Proxalutamide (meta)
Ensitrelvir (meta) Quercetin (meta)
Ensovibep (meta) Remdesivir (meta)
Exercise (meta) Sleep (meta)
Famotidine (meta) Sotrovimab (meta)
Favipiravir (meta) Tixagev../c.. (meta)
Fluvoxamine (meta) Vitamin A (meta)
Hydroxychlor.. (meta) Vitamin C (meta)
Iota-carragee.. (meta) Vitamin D (meta)
Ivermectin (meta) Zinc (meta)

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent: 
0 0.5 1 1.5 2+ Mortality 76% Improvement Relative Risk Hospitalization 51% c19early.com/ex Buckley et al. Exercise for COVID-19 Favors exercise Favors inactivity
Buckley, 1,286 patient exercise study: 76% lower mortality [p<0.0001] and 51% lower hospitalization [p<0.0001] https://c19p.org/buckley
copied to clipboard
Exercise rehabilitation associates with lower mortality and hospitalisation in cardiovascular disease patients with COVID-19
Buckley et al., European Journal of Preventive Cardiology, doi:10.1093/eurjpc/zwaa135
5 Jul 2021    Source   PDF   Share   Tweet
PSM retrospective 643 COVID-19 patients with cardiovascular disease undergoing exercise rehabilitation within 3 months of diagnosis, showing significantly lower re-hospitalization and mortality with exercise rehabilitation.
risk of death, 75.8% lower, RR 0.24, p < 0.001, high activity levels 10 of 639 (1.6%), low activity levels 41 of 638 (6.4%), NNT 21, odds ratio converted to relative risk.
risk of hospitalization, 50.9% lower, RR 0.49, p < 0.001, high activity levels 97 of 643 (15.1%), low activity levels 198 of 643 (30.8%), NNT 6.4, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Buckley et al., 7/5/2021, retrospective, USA, North America, peer-reviewed, 7 authors.
All Studies   Meta Analysis
Please send us corrections, updates, or comments. Vaccines and treatments are both valuable and complementary. All practical, effective, and safe means should be used. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases mortality, morbidity, collateral damage, and the risk of endemic status. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit